comparemela.com

Latest Breaking News On - Rafael romaguera - Page 1 : comparemela.com

Cre8 EVO Stents Noninferior for Percutaneous Coronary Intervention in Diabetes Patients With CAD

For patients with diabetes mellitus and coronary artery disease who require percutaneous coronary intervention, the Cre8 EVO stent is noninferior to Resolute Onyx stents for a composite outcome of target-lesion failure.

Amphilimus-eluting stents superior to zotarolimus stents in diabetics undergoing PCI: SUGAR trial

Spain: Cre8 EVO stents (polymer-free amphilimus-eluting stent) are superior to Resolute Onyx stents (polymer-based zotarolimus-eluting stent) in patients with diabetes undergoing PCI with regard to.

Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD

Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.